key: cord-0720348-4f8frvk5
authors: Sarjerao Shirkande, Abhijeet; Abhijeet Shirkande, Ankita
title: Ayurvedic evaluation and treatment of Covid 19: A Case Report
date: 2021-07-14
journal: J Ayurveda Integr Med
DOI: 10.1016/j.jaim.2021.07.005
sha: 7ec1c09bd3ef4251ff9d141e140ada4ef8b20495
doc_id: 720348
cord_uid: 4f8frvk5

COVID-19 patients, with underlying comorbidities are observed to develop complications. Studies have shown that hypertension (one of the comorbidities) is a risk factor for patients with severe COVID-19. There have been more patients with hypertension among those who have died than among survivors. There is no proven treatment of COVID-19 as of now. Ministry of AYUSH, Government of India, has permitted use of traditional systems of medicine for treating mild to moderate cases of COVID-19. In line with this, there are few case reports which show promising results for treatment of COVID-19 with Ayurveda treatment module. These treatment reports highlight subdued COVID-19 infection without developing serious complications. Case in the paper is of a young hypertensive female patient with fever, weakness, anosmia, tastelessness and severe myalgia who was diagnosed with COVID-19. Ayurvedic assessment for this was Kaphavataj jwara. The patient sought Ayurvedic treatment. She was advised with treatment module including medicines, diet and behavioral interventions. Though patient was having comorbid hypertension with major COVID-19 symptoms, tested negative and recovered with exclusive Ayurvedic treatment. The patient was recovered both physically as well as psychologically with no post COVID-19 complications so far. Ayurvedic treatment module appears to be safe and efficacious with early recovery and better outcomes.

India is the second most affected country by COVID-19 with 8.14 million cases. Pune (Maharashtra) has one of the highest case-loads in India. Conspicuously, Pune also has significant Ayurveda practicing population indicating its awareness about Ayurveda. The patient in this case report belongs to Pune. Ministry of AYUSH, Government of India, has permitted use of traditional systems of medicines as authorized treatment for mild to moderate cases of Covid 19 disease 1 . This young female patient who diagnosed with Covid-19 (RT-PCR) was hypertensive. COVID-19 patients with comorbid hypertension could have worse outcomes including severe rise in infection or complications leading to mortality 2 . The patient willingly chose to undertake Ayurvedic treatment. Despite of comorbid hypertension, this patient recovered physically and psychologically in a short duration of time with no post Covid-19 complications as yet. This case report can be a demonstration/ layout for examining and treating COVID-19 cases accompanied by a comorbid hypertension with Ayurveda effectively and safely.

A 37 years, female, medium statured (Weight: 49 kg, Height: 155 cm), software engineer by profession from Pune, India, approached to her Ayurvedic family physician on 28/07/2020. Patient is known case of Hypertension since 2019 and was on Ayurvedic medication for the same., she was having fatigue, fever 100 0 F, irritation in throat, myalgia. Blood pressure was 134/90mmHg. Patient felt above symptoms three days after her colleague found COVID-19 positive. Ayurvedic examination for current symptoms was conducted with all precautions. Fatigue (Vata domination), Fever (Kapha Vata dominated Jwara), irritation in throat (Kapha vitiation), myalgia (Kapha and Vata vitiation), hypertension in her case (Vata Pitta vitiation) was analysed as Kapha Vata vitiation. Her body constitution is Vata Pitta Prakriti, Medium sattva (Psychic state), Agnimandya ( Low digestive power), Nadi (Pulse): Pittapradhan, Vatanubadhi, Tongue: Sama (coated), Koshtha: Medium ( nature of digestive tract), Mala (Faeces): Sama mala (Foul smelling, sticky stools), Mutra (Urine): pale yellow, 6 to 7 times per day, no burning sensation. Her body temperature was 100 0 F and Blood pressure was 134/90mmHg. All Ayurvedic finding leads to diagnosis as Kapha Vataj Jwara.

Patient was advised testing for COVID-19 RT-PCR swab test on the same day which came positive for Covid 19 disease. Patient isolated herself at home as per the instruction of concerned doctor from Government authorized COVID Centre. She telephonically contacted the Ayurvedic physician soon after. The conversation cum consolation relieved the family from stress after which Ayurvedic medication was started. Home isolation, sanitary practices, blood pressure, pulse rate, peripheral oxygen saturation monitoring were advised and instructed. Written informed consent for Ayurvedic treatment and case report publication was obtained from patient. Family History Patient's father is known case of type 2 diabetes along with Hypertension and on allopathic prescribed medicines. Her mother has diagnosed gout and type 2 diabetes. She is having good control over with prescribed Ayurvedic medicines. Patient's brother and elder sister are asthmatic and rely on Ayurvedic prescribed medicines.

Patient had Ankle joint swelling (2015), Urticaria (2016), Hyperacidity (2017), Weight gain (2018), Headache (2018), Hypertension (2019). Patient was treated with Ayurvedic medicines for above mentioned complaints successfully. Her hypertension is in control with Ayurvedic treatment and regimen. Earlier in July 2020, she consulted me for Garbhasanskara(Ayurvedic prenatal care) and advised Padmakashtha Phanta-30 ml twice a day, Tab Uterotone -250 mg twice a day, Shatavari Kalp -10 gms once a day & Shamaka Yoga 2.5gm twice a day. She was on the above prescription from 27.06.2020 for a period of one month. She stopped these medicines as soon as she developed a fever. Diet pattern prior to illness-Breakfast (8-8. Table 1 and Table 2 .

After diagnosis and till recovery every follow-up was taken telephonically. After positive detection of RTPCR for Covid 19, further investigations were advised, LDH, D-Dimer, CRP, Sr. Ferritin and HRCT. Monitoring of blood pressure, pulse rate, peripheral oxygen saturation was advised. All further follow ups were undertaken telephonically, as mentioned in Table 1 . The patient recorded and reported the vital check points regularly. This helped us to diagnose the stages of the disease and recommend medicine prescription accordingly ( COVID-19 patients with hypertension were more likely to have severe pneumonia, excessive inflammatory reactions, organ and tissue damage, and deterioration of the disease than patients without hypertension 11 . The prognostic outlook of COVID-19 in Ayurveda perspective can be understood as Jwara (In this case -Kapha Vata Fever) -Raktapitta (Hematic pathologies -Kapha-Vata dominated)-Shwasa and Kasa (Severe respiratory distress -Kapha Vata dominance). Chronological evolution is base of every science. Ayurveda has explained the chapters in same way. In the diagnostic part, different pathologies of fever has been elaborated, keeping Rasadhatu at centre. Pitta is the essential driver of Jwara which is also key factor for Raktapitta. In majority of cases consistent fever is responsible for blood pathologies. 14 . Dashang dhoopana (Ayurvedic fumigation) used as potent disinfectant of rooms and environment. It helps preventing outbreak of epidemics and pandemics 15 . Shadangodak (medicated water) has been mentioned in Jwara treatment for Aampachana (Digestion of body toxins) and Pitta maintenance 14 . So found helpful in prevention of prognosis. In second stage, after Ama pachana (Digestion of indigested body toxins), only Sitopaladi Churna was continued for improving Agni and Dhatu strength. This medicine has been listed for Rajayakshama in Ayurveda and majorly prescribed for tuberculosis, viral respiratory infection, pneumonia, bronchitis, pharyngeal and chest congestion 16 . Broadly, Sitopaladi churna has affinity towards Pranavaha Srotas (Respiratory system). So might be useful in post Covid lung complications. Considering the body constitution of patient (Vata Pitta Prakriti), Past complaints, Present Varsha ritu (Rainy season) and related Pitta dosha sanchaya (natural accumulation of Pitta dosha) and coming season (Sharad -Pitta Prakop kala) Shadangodak and Sitopaladi Churna has been selected to maintain Pitta dosha. In the recovery stage, Vyadhisthana viz affected organ has been targeted. Drakshasava is one of the choicest medicines in respiratory tract diseases, has dried fruits of Vitis vinifera as chief ingredient. It has proven potential against ongoing inflammatory process underlying respiratory problems through inhibition of histamine release, cytokine production, improving lung functioning by counteracting allergen induced bronchial hyper responsiveness; and blocking the release of inflammatory cellular infiltration (eosinophil, lymphocytes, neutrophils) into airways 17 . Apart from treatment, dietetic and behavioral regimen are the key factors in Ayurveda treatment. Controlled eating regimen was advised with the aim of fixing disturbed Dosha, Agni and Bala. The diet followed the Jwara treatment Sutra viz light to digest, strengthening to body and mind, helpful in restoring digestive fire. Pranayama makes efficient use of abdominal and diaphragmatic muscles and improves the respiratory apparatus 18 .The patient had recovered in seven days, didn't intensify considering the comorbid hypertension. Thus, it can be said that the span of the ailment was probably shorter in view of the Ayurvedic medications as it was noted where traditional Chinese medicine was utilized 19 

Written informed consent was obtained from patient before initiation of treatment. A written informed consent for publication of patients clinical details was obtained from her.

Patient has isolated herself at home and all family members were following strict sanitization, social distancing and masking practices. Besides, they were following recommended Ayurvedic diet and regimen (Table 2 ). Considering the probability of transmission of COVID-19 within families of infected individuals (though it is low), a body dosha balance upholding medication-Shrugyadi Decoction 20ml, Morning (once a day) has been started. The combined effect of above said practices sought good results for this case. This aspect need to be explored as future research challenges.

MINISTRY OF AYUSH Government of India Interdisciplinary AYUSH Research & Development Task Force Guidelines for AYUSH Clinical Studies in COVID-19

Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med

Vd Vasudev Panshikar

Nighantu ratnakar part 2; Jwar prakaran; Kanthakubaja Sannipat;Delhi; Chaukhamba Sanskrit Pratishthan

Vd Vasudev Panshikar

Nighantu ratnakar part 2; Jwar prakaran; Sannipatjwara;Delhi; Chaukhamba Sanskrit Pratishthan

Sarth Vagbhat; Uttarsthana; Sarpvishapratishedh; Chapter 36; Verse 84-85; Pune; Chintamani printers

Sarth Vagbhat; Chikitsa sthana; Jwarachikitsa; Chapter 1; Verse 15; Pune; Chintamani printers

Sarth Vagbhat; Uttarsthana; Kitalutadivisha pratishedh

Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report

COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study

Verse 1; Varanasi; Chwokhamba Prakashana

Ministry of AYUSH, Government of India

Physico-chemical standardization of Sitopaladi churna

Investigation of anti-asthmatic potential of dried fruits of Vitis vinifera L. in animal model of bronchial asthma

Effect of short term yoga practice on ventilatory function tests

Traditional Chinese medicine for COVID-19 treatment

Host-microbiota interactions: from holobiont theory to analysis. Microbiome

The authors whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants

membership, employment, consultancies, stock ownership, or other equity interest

and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations

Dr Abhijeet Sarjerao Shirkande

Dr Ankita Abhijeet Shirkande